https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

FDA approved the first rapid-acting biosimilar insulin product, Merilog (insulin-aspart-szij), a biosimilar to its reference product Novolog (insulin aspart), to improve glycemic control in adults and children with diabetes mellitus.

administrator

Related Articles